166 related articles for article (PubMed ID: 34534614)
21. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
[TBL] [Abstract][Full Text] [Related]
22. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
23. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
[TBL] [Abstract][Full Text] [Related]
24. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
25. Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation.
Bolsi A; Placidi L; Pica A; Ahlhelm FJ; Walser M; Lomax AJ; Weber DC
Radiother Oncol; 2020 Aug; 149():197-204. PubMed ID: 32387488
[TBL] [Abstract][Full Text] [Related]
26. Calculating dose-averaged linear energy transfer in an analytical treatment planning system for carbon-ion radiotherapy.
Wang W; Li P; Shahnazi K; Wu X; Zhao J
J Appl Clin Med Phys; 2023 Feb; 24(2):e13866. PubMed ID: 36527366
[TBL] [Abstract][Full Text] [Related]
27. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
28. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy.
Fjæra LF; Indelicato DJ; Handeland AH; Ytre-Hauge KS; Lassen-Ramshad Y; Muren LP; Stokkevåg CH
Radiother Oncol; 2022 Oct; 175():47-55. PubMed ID: 35917900
[TBL] [Abstract][Full Text] [Related]
29. RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy.
Liu C; Bradley JA; Zheng D; Vega RBM; Beltran CJ; Mendenhall N; Liang X
J Appl Clin Med Phys; 2022 Apr; 23(4):e13527. PubMed ID: 35060317
[TBL] [Abstract][Full Text] [Related]
30. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
31. Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target.
Bertolet A; Carabe A
Phys Med Biol; 2020 Aug; 65(16):165006. PubMed ID: 32428896
[TBL] [Abstract][Full Text] [Related]
32. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
33. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
[TBL] [Abstract][Full Text] [Related]
34. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
[TBL] [Abstract][Full Text] [Related]
35. Robust Optimization for Intensity Modulated Proton Therapy to Redistribute High Linear Energy Transfer from Nearby Critical Organs to Tumors in Head and Neck Cancer.
Liu C; Patel SH; Shan J; Schild SE; Vargas CE; Wong WW; Ding X; Bues M; Liu W
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):181-193. PubMed ID: 31987967
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
[TBL] [Abstract][Full Text] [Related]
37. Investigating the impact of alpha/beta and LET
Mara E; Clausen M; Khachonkham S; Deycmar S; Pessy C; Dörr W; Kuess P; Georg D; Gruber S
Med Phys; 2020 Aug; 47(8):3691-3702. PubMed ID: 32347564
[TBL] [Abstract][Full Text] [Related]
38. First experience with model-based selection of head and neck cancer patients for proton therapy.
Tambas M; Steenbakkers RJHM; van der Laan HP; Wolters AM; Kierkels RGJ; Scandurra D; Korevaar EW; Oldehinkel E; van Zon-Meijer TWH; Both S; van den Hoek JGM; Langendijk JA
Radiother Oncol; 2020 Oct; 151():206-213. PubMed ID: 32768508
[TBL] [Abstract][Full Text] [Related]
39. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
40. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
